US Patent Issued to NATCO PHARMA on Oct. 27 for "EGFR inhibitor for the treatment of head and neck cancer" (Indian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,410, issued on Oct. 27, was assigned to NATCO PHARMA Ltd. (Hyderabad, India).

"EGFR inhibitor for the treatment of head and neck cancer" was invented by Sheshu Babu Yadla (Hyderabad, India), Praveen Chowdary Myneni (Hyderabad, India), Venkata Ramana Gogula (Hyderabad, India) and Venkaiah Chowdary Nannapaneni (Hyderabad, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl...